{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T01:00:54Z","timestamp":1760576454242,"version":"build-2065373602"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013398","name":"Sykehuset Innlandet HF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Trace Elements in Medicine and Biology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jtemb.2021.126915","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T05:38:05Z","timestamp":1639633085000},"page":"126915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Skogholt\u2019s disease\u2014A tauopathy precipitated by iron and copper?"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2773-8227","authenticated-orcid":false,"given":"Klaus T.","family":"Aspli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trygve","family":"Holm\u00f8y","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trond Peder","family":"Flaten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon Elling","family":"Whist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7518-5703","authenticated-orcid":false,"given":"Jan O.","family":"Aaseth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"GBD Compare Data Visualization","author":"Institute for Health Metrics and Evaluation (IHME)","key":"10.1016\/j.jtemb.2021.126915_bib0005"},{"key":"10.1016\/j.jtemb.2021.126915_bib0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","article-title":"Basic mechanisms of neurodegeneration: a critical update","volume":"14","author":"Jellinger","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jtemb.2021.126915_bib0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of amyloid hypothesis and tau hypothesis in alzheimer\u2019s disease","volume":"12","author":"Kametani","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jtemb.2021.126915_bib0020","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41593-018-0237-7","article-title":"Converging pathways in neurodegeneration, from genetics to mechanisms","volume":"21","author":"Gan","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jtemb.2021.126915_bib0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10495-008-0301-y","article-title":"Cell death: protein misfolding and neurodegenerative diseases","volume":"14","author":"Nakamura","year":"2009","journal-title":"Apoptosis."},{"key":"10.1016\/j.jtemb.2021.126915_bib0030","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archneur.55.11.1467","article-title":"Progressive central and peripheral demyelinating disease of adult onset in a Norwegian family","volume":"55","author":"Hagen","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jtemb.2021.126915_bib0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jns.2007.08.042","article-title":"Trace elements in cerebrospinal fluid and blood from patients with a rare progressive central and peripheral demyelinating disease","volume":"266","author":"Gellein","year":"2008","journal-title":"J. Neurol. Sci."},{"year":"2006","series-title":"Genetic Analysis of a New Disease Entity: Progressive Central and Peripheral Demyelinating Disease","author":"Skogholt","key":"10.1016\/j.jtemb.2021.126915_bib0040"},{"year":"2007","series-title":"Genetic Mapping of Progressive Central and Peripheral Demyelinating Disease in a Norwegian Family","author":"Bentsen H\u00e5vik","key":"10.1016\/j.jtemb.2021.126915_bib0045"},{"key":"10.1016\/j.jtemb.2021.126915_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2014.12.002","article-title":"Iron and copper in progressive demyelination \u2013 new lessons from Skogholt\u2019s disease","author":"Aspli","year":"2015","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.jtemb.2021.126915_bib0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40035-020-00189-z","article-title":"Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease","volume":"9","author":"Wang","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jtemb.2021.126915_bib0060","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00775-019-01731-9","article-title":"Redox active metals in neurodegenerative diseases","volume":"24","author":"Acevedo","year":"2019","journal-title":"J. Biol. Inorg. Chem. JBIC Publ. Soc. Biol. Inorg. Chem."},{"key":"10.1016\/j.jtemb.2021.126915_bib0065","doi-asserted-by":"crossref","first-page":"e00776","DOI":"10.1002\/brb3.776","article-title":"Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline","volume":"7","author":"Eliassen","year":"2017","journal-title":"Brain Behav."},{"key":"10.1016\/j.jtemb.2021.126915_bib0070","first-page":"167","article-title":"Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming","volume":"14","author":"Tombaugh","year":"1999","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.jtemb.2021.126915_bib0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"year":"2008","series-title":"MMSE-NR3 Norsk Revidert Mini Mental Status Evaluering (Revidert Og Utvidet Manual)","author":"Strobel","key":"10.1016\/j.jtemb.2021.126915_bib0080"},{"year":"2015","series-title":"Psychometric Assessment of the Clock Drawing Test","author":"Smedslund","key":"10.1016\/j.jtemb.2021.126915_bib0085"},{"journal-title":"Norsk Revidert Klokketest (KT-NR3)","year":"2018","author":"Strobel","key":"10.1016\/j.jtemb.2021.126915_bib0090"},{"key":"10.1016\/j.jtemb.2021.126915_bib0095","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.jtemb.2021.126915_bib0100","unstructured":"C. Strobel, H. Johansen, O. Aga, P. Bekkhus-Wetterberg, M. Brierley, J. Egeland, K. Folles\u00f8, P.-O. Rike, A.-K. Schanke, Manual Norsk Revidert Trail Making Test (TMT- NR3), (2018)."},{"key":"10.1016\/j.jtemb.2021.126915_bib0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"year":"2020","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","key":"10.1016\/j.jtemb.2021.126915_bib0110"},{"key":"10.1016\/j.jtemb.2021.126915_bib0115","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"Int. J. Open Source Softw. Process."},{"year":"2016","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","key":"10.1016\/j.jtemb.2021.126915_bib0120"},{"key":"10.1016\/j.jtemb.2021.126915_bib0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0887-6177(03)00039-8","article-title":"Trail making Test A and B: normative data stratified by age and education","volume":"19","author":"Tombaugh","year":"2004","journal-title":"Arch. Clin. Neuropsychol. Off. J. Natl. Acad. Neuropsychol."},{"key":"10.1016\/j.jtemb.2021.126915_bib0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3233\/JAD-2000-23-402","article-title":"Cerebrospinal fluid markers for Alzheimer\u2019s disease evaluated after acute ischemic stroke","volume":"2","author":"Hesse","year":"2000","journal-title":"J. Alzheimers Dis. JAD."},{"key":"10.1016\/j.jtemb.2021.126915_bib0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-8454-7-10","article-title":"Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid","volume":"7","author":"Selnes","year":"2010","journal-title":"Cerebrospinal Fluid Res."},{"key":"10.1016\/j.jtemb.2021.126915_bib0140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12883-020-01753-w","article-title":"No evidence for amyloid pathology as a key mediator of neurodegeneration post-stroke - a seven-year follow-up study","volume":"20","author":"Hagberg","year":"2020","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jtemb.2021.126915_bib0145","article-title":"CSF tau and the CSF tau\/ABeta ratio for the diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI)","volume":"3","author":"Ritchie","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jtemb.2021.126915_bib0150","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pharmthera.2011.10.006","article-title":"Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases","volume":"133","author":"Zheng","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jtemb.2021.126915_bib0155","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1212\/WNL.0000000000005030","article-title":"Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy","volume":"90","author":"Charidimou","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.jtemb.2021.126915_bib0160","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pneurobio.2017.10.001","article-title":"Blood-brain barrier dysfunction and recovery after ischemic stroke","volume":"163\u2013164","author":"Jiang","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jtemb.2021.126915_bib0165","doi-asserted-by":"crossref","first-page":"C135","DOI":"10.1152\/ajpcell.00136.2018","article-title":"Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke","volume":"316","author":"Yang","year":"2019","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"10.1016\/j.jtemb.2021.126915_bib0170","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jalz.2019.01.013","article-title":"Quantifying blood-brain barrier leakage in small vessel disease: review and consensus recommendations","volume":"15","author":"Thrippleton","year":"2019","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"10.1016\/j.jtemb.2021.126915_bib0175","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1471-4159.1997.69020443.x","article-title":"Transport of iron in the blood-brain-cerebrospinal fluid system","volume":"69","author":"Bradbury","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jtemb.2021.126915_bib0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4155\/fmc.09.140","article-title":"Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders","volume":"2","author":"Mills","year":"2010","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jtemb.2021.126915_bib0185","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00018-014-1771-4","article-title":"Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy","volume":"72","author":"McCarthy","year":"2015","journal-title":"Cell. Mol. Life Sci. CMLS."},{"key":"10.1016\/j.jtemb.2021.126915_bib0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.apcsb.2020.09.002","article-title":"The role of transferrins and iron-related proteins in brain iron transport: applications to neurological diseases","volume":"123","author":"Campos-Escamilla","year":"2021","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.jtemb.2021.126915_bib0195","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/jnc.13040","article-title":"Molecular mechanisms of non-transferrin-bound and transferring-bound iron uptake in primary hippocampal neurons","volume":"133","author":"Ji","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jtemb.2021.126915_bib0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-4165(85)90115-1","article-title":"Binding of manganese in human and rat plasma","volume":"840","author":"Scheuhammer","year":"1985","journal-title":"Biochim. Biophys. Acta BBA - Gen. Subj."},{"key":"10.1016\/j.jtemb.2021.126915_bib0205","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2008.10.056","article-title":"Copper transport to the brain by the blood-brain barrier and Blood-CSF barrier","volume":"1248","author":"Choi","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.jtemb.2021.126915_bib0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4161\/pri.2.1.6297","article-title":"Ceruloplasmin fragmentation is implicated in \u201cfree\u201d copper deregulation of Alzheimer\u2019s disease","volume":"2","author":"Squitti","year":"2008","journal-title":"Prion."},{"key":"10.1016\/j.jtemb.2021.126915_bib0215","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jinorgbio.2018.10.009","article-title":"Chelating principles in Menkes and Wilson diseases: choosing the right compounds in the right combinations at the right time","volume":"190","author":"Horn","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jtemb.2021.126915_bib0220","article-title":"Trace elements in the large population-based HUNT3 survey","author":"Syversen","year":"2020","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.jtemb.2021.126915_bib0225","series-title":"Handb. Toxicol. Met.","first-page":"765","article-title":"Copper","author":"Ellingsen","year":"2014"},{"key":"10.1016\/j.jtemb.2021.126915_bib0230","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3233\/JAD-2010-101473","article-title":"Copper in Alzheimer\u2019s disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies","volume":"24","author":"Bucossi","year":"2011","journal-title":"J. Alzheimers Dis. JAD."},{"key":"10.1016\/j.jtemb.2021.126915_bib0235","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jtemb.2014.10.001","article-title":"Chelation in metal intoxication--Principles and paradigms","volume":"31","author":"Aaseth","year":"2015","journal-title":"J. Trace Elem. Med. Biol. Organ Soc. Miner. Trace Elem. GMS."},{"key":"10.1016\/j.jtemb.2021.126915_bib0240","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jtemb.2014.05.007","article-title":"The neurotoxicity of iron, copper and manganese in Parkinson\u2019s and Wilson\u2019s diseases","volume":"31","author":"Dusek","year":"2015","journal-title":"J. Trace Elem. Med. Biol. Organ Soc. Miner. Trace Elem. GMS."},{"key":"10.1016\/j.jtemb.2021.126915_bib0245","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2174\/1871527311312050015","article-title":"Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities","volume":"12","author":"Rodrigo","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.jtemb.2021.126915_bib0250","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.2174\/1381612826666200708133912","article-title":"Pathophysiology of ischemic stroke: role of oxidative stress","volume":"26","author":"Orellana-Urz\u00faa","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jtemb.2021.126915_bib0255","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s11064-008-9610-3","article-title":"Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases","volume":"33","author":"Boll","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jtemb.2021.126915_bib0260","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/nbdi.1999.0250","article-title":"The role of copper in neurodegenerative disease","volume":"6","author":"Waggoner","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jtemb.2021.126915_bib0265","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer\u2019s disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jtemb.2021.126915_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00204-015-1579-5","article-title":"Redox- and non-redox-metal-induced formation of free radicals and their role in human disease","volume":"90","author":"Valko","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jtemb.2021.126915_bib0275","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death Nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jtemb.2021.126915_bib0280","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00726-010-0777-y","article-title":"Advanced glycation endproducts and their pathogenic roles in neurological disorders","volume":"42","author":"M\u00fcnch","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.jtemb.2021.126915_bib0285","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12011-014-9956-0","article-title":"Serum arsenic and lipid peroxidation levels in patients with multiple sclerosis","volume":"158","author":"Yousefi","year":"2014","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.jtemb.2021.126915_bib0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17041269","article-title":"Xenobiotics, Trace Metals and Genetics in the Pathogenesis of Tauopathies","volume":"17","author":"Aaseth","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jtemb.2021.126915_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2012.02.018","article-title":"Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective","volume":"317","author":"Li","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jtemb.2021.126915_bib0300","first-page":"827","article-title":"Treatment strategies in Alzheimer\u2019s disease: a review with focus on selenium supplementation","volume":"29","author":"Aaseth","year":"2016","journal-title":"Biometals Int. J. Role Met. Ions Biol. Biochem. Med."},{"key":"10.1016\/j.jtemb.2021.126915_bib0305","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.2174\/092986712800609689","article-title":"Chelating agents for neurodegenerative diseases","volume":"19","author":"Ward","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jtemb.2021.126915_bib0310","first-page":"252","article-title":"Iron and ferroptosis as therapeutic targets in alzheimer\u2019s disease","volume":"18","author":"Gleason","year":"2021","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."}],"container-title":["Journal of Trace Elements in Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0946672X21002054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0946672X21002054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:14:39Z","timestamp":1760555679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0946672X21002054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":62,"alternative-id":["S0946672X21002054"],"URL":"https:\/\/doi.org\/10.1016\/j.jtemb.2021.126915","relation":{},"ISSN":["0946-672X"],"issn-type":[{"type":"print","value":"0946-672X"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skogholt\u2019s disease\u2014A tauopathy precipitated by iron and copper?","name":"articletitle","label":"Article Title"},{"value":"Journal of Trace Elements in Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtemb.2021.126915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"126915"}}